Search
for
Sort by
Research 331–360 of 341
- Application of the waiting time distribution in a nationwide screening of real‐world dermatology drug utilization for aberrant use patterns
- Confocal microscopy and optical coherence tomography of inflammatory skin diseases in hairs and pilosebaceous units: A systematic review
- Active Compounds with Medicinal Potential Found in Maxillariinae Benth. (Orchidaceae Juss.) Representatives—A Review
- Association of Acne Tarda with Endocrinological Disorders
- The Non-Cosmetic Dermatological Use of Botulinum Neurotoxin
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Activation of TRPV3 Regulates Inflammatory Actions of Human Epidermal Keratinocytes
- An Updated Review of Topical Tretinoin in Dermatology: From Acne and Photoaging to Skin Cancer
- Modulating the Gut–Skin Axis in Dermatological Diseases: Mechanisms and Clinical Applications of Probiotics, Prebiotics, Synbiotics, and Postbiotics
- Hair restoration surgery: pre-surgical considerations and pitfalls
- Surgical Management of Scarring Alopecia
- Papulopustular eruptions associated with EGFR-pathway-related targeted therapies: clinical spectrum, evidence boundaries, folliculocentric inflammation, and management considerations
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- Histopathologic features of erythematous papulopustular eruption to epidermal growth factor receptor inhibitors in cancer patients
- Cutaneous Drug Eruptions Associated with the Use of New Oncological Drugs
- 176 Hair eruption initiates adverse events of EGFR-targeted cancer therapy
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Chemotherapy-induced iatrogenic injury of skin: New drugs and new concepts
- A distinct cutaneous reaction to sorafenib and a multikinase inhibitor
- Cutaneous adverse events to systemic antineoplastic therapies: a retrospective study in a public oncologic hospital
- Cutaneous Adverse Events of Targeted Anticancer Therapy: A Review of Common Clinical Manifestations and Management
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Mitigation of epidermal growth factor receptor inhibitor-induced side effects utilizing melanin and vascular-specific lasers: A case report series
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- 129 Targeted inhibition of EGFR reduces anti-microbial defense mechanisms at the hair canal
- Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients and vaccine-associated dermatoses: a large original study of a general COVID-19 centers from Iran
- Treatment of acne with intermittent isotretinoin, cohort study
- Dermatologic Side Effects of Systemic Targeted Anticancer Therapy